CLABSI Prevention Device — image 1
CLABSI Prevention Device — image 2
CLABSI Prevention Device — image 3
CLABSI Prevention Device — image 4
CLABSI Prevention Device — image 5

CLABSI Prevention Device

Senior Capstone
Embedded SystemsPCB DesignZephyr RTOSMedical DeviceDuke BME

A handheld UV-C disinfection device for central-line hubs, developed at Duke University's Pratt School of Engineering.

View on GitHub
D. Bearden · D. Chong · N. Kodua · F. Rudd · N. Trigger|Dept. of Biomedical Engineering, Duke University
Shutoff Time
17 ms
450 ms limit (ISO 15858)
CFU Reduction
4-log
EPA OCSPP 810.2200
Device Weight
204 g
One-handed operation
UV-C Bandwidth
263–273 nm
2.49 ± 0.047 mW optical

Problem & Need

Central Line-Associated Bloodstream Infections (CLABSIs) occur when bacteria enter the bloodstream via a central line. 40,000 CLABSIs occur annually in the US, costing hospitals approximately $1.9B per year — and 65–70% are completely preventable with proper disinfection.

The current standard of care is the Scrub-the-Hub technique, which relies entirely on nurse compliance with manual protocol. Infections arise from human error and inconsistent adherence to workflow. This device removes that dependency.

Need Statement: Hospital nurses need a quick, reliable, and user-friendly system to disinfect central lines to maintain adherence to proper protocols and reduce infection risk in patients.


Why UV-C Disinfection?

DNA and RNA strongly absorb 260 nm UV-C incident light. The high-energy photons create nitrogenous base lesions, distorting the helix structure and blocking transcription and translation — effectively sterilizing the hub surface without chemicals, contact, or manual technique.


Device Design

Mechanical

The enclosure is resin-printed to prevent UV-C light leakage. Key mechanical elements:

#ComponentRole
1Resin-Printed CasingContains UV-C, prevents leakage
2Disinfection ChamberWhere the catheter hub is inserted
3RGB LEDColor-coded status during operation and errors
4Activation ButtonSingle-button start/abort
5Opening ApertureSeals around the catheter to prevent leakage
6Safety Interlocks (×2)Abort if device opens prematurely

Electrical

Three custom KiCad PCBs make up the electrical system:

BoardFunction
MainnRF54L15 MCU, power management, BMS (MAX17260), RGB LED driver (LP5815)
UVCUV-C LED driver with current-limiting elements
BaseMechanical base and connector board

Firmware

Written in C on Zephyr RTOS (nRF Connect SDK), targeting the nRF54L15. The application runs a hierarchical state machine (Zephyr SMF):

INIT → IDLE ──► DISINFECTING ──► IDLE
            ──► CHARGING      ──► (abort via button or interlock)
            ──► ERROR
StateBehavior
INITInitialize GPIO, PWM, I2C, BMS, safety interlocks
IDLEAwaiting button press; battery SOC displayed on RGB LED
CHARGINGCharge in progress; RGB indicates charge level
DISINFECTINGUV-C LED at full PWM; instant abort on interlock open or button press
ERRORRGB error pattern + buzzer; cleared by button press

The critical safety path: interlock GPIO interrupts submit a work item that disables PWM output before the SMF state transition completes — mean shutoff time of 17 ± 2 ms, well within the 450 ms safety limit derived from ISO 15858.


Testing Results

MetricValue
Device Weight204 g
UV-C LED Optical Power2.49 ± 0.047 mW
UV-C LED Bandwidth262.9 – 273.2 nm
Rapid Shutoff Time17 ± 2 ms (limit: <450 ms)
Germicidal CFU Reduction4-log reduction (n=3 replicates)

Germicidal testing used DH5α bacteria incubated, seeded, and adhered to catheter hubs at room temperature. Hubs were irradiated with UV-C at 0, 2, and 4 hours, then vortexed for CFU counts by serial dilution — achieving a 4-log reduction.


Regulatory & Market

The CLAB-Free device will be classified as a Class II FDA device given the inherent risk of UV light and catheter use. Two potential pathways:

  • 510(k) — Preferred: If determined similar enough to existing UV surface-disinfecting devices
  • De Novo: If disinfection through catheter tubing constitutes a novel use case
Total Available Market
~$1.61B
Global catheter-related bloodstream infection market (2024)
Serviceable Available Market
~$481M
US central-line infection market (minimum estimate)
Serviceable Obtainable Market
~$16.1M
5% of preventable CLABSIs

Conclusion & Next Steps

The device successfully disinfects central line hubs using UV-C light in the germicidal range, achieves a 4-log CFU reduction, and operates safely within ISO 15858 exposure limits. It is portable, one-handed, and reusable between patients.

Planned next steps:

  • Nurse usability testing
  • Design of docking/recharging stations
  • Autoclavable disinfection chamber redesign
  • Head-to-head testing against proper and improper Scrub-the-Hub technique

Project Documents

© 2026 Nicholas Trigger